In this letter, NAMD offers initial recommendations on program integrity to the Centers for Medicare and CHIP Services (CMCS) and the Center for Program Integrity (CPI) to inform these agencies’ ongoing work to modernize the Medicaid managed care regulations. These recommendations focus on provider enrollment, encounter and claims data, compliance and staffing, and benefit alignment. […]
NAMD submitted a letter to Senate Finance Committee Chairman Ron Wyden and Committee Member Charles Grassley which offer recommendations to better streamline the use of health care data to accelerate high value reforms in the health care system. The letter responds to the Senators’ June 12 open letter to stakeholders. Read the full letter here.
Million Hearts is a national initiative to prevent one million heart attacks and strokes by 2017. Through this effort, private and public partners, including Medicaid and public health agencies, have been collaborating since September 2011 to enhance cardiovascular disease (CVD) prevention and achieve this goal. This fact sheet, which is being released in partnership with […]
Through Medicaid-led initiatives, federal grants and programs, and multi-payer efforts, Medicaid directors are actively engaged in efforts to improve quality, contain costs and increase the value of the Medicaid investment. One tool for system reform is the Delivery System Reform Incentive Pool (DSRIP). In DSRIP, states procure a Section 1115 waiver that allows the state […]
NAMD and the National Association of State Mental Health Program Directors (NASMHPD) submitted joint comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on regulations governing the confidentiality of substance use disorder health information (42 CFR Part 2). Among other recommendations, the letter urges SAMHSA to align the privacy requirements governing alcohol and […]
The National Association of Medicaid Directors released a public memo which discusses average acquisition cost (AAC) methodologies for Medicaid prescription drug reimbursement. The memo also provides an update on CMS’s progress finalizing average market price-based Federal Upper Limits (AMP-based FULs) for prescription drugs. Read the full memo here.
The National Association of Medicaid Directors (NAMD), the National Association of State Directors of Developmental Disabilities Services (NASDDDS), and the National Association of States United for Aging and Disabilities (NASUAD) joined together to send a letter to the Centers for Medicare and Medicaid Services (CMS) concerning the new home and community-based services (HCBS) regulation. Read […]
As the pace of payment and delivery system reform accelerates in Medicaid programs, state agencies have begun to emerge as thought leaders and major players in health care data analytics. Medicaid programs are increasingly using internal and external expertise to realign payment and quality measurement in order to set their programs on the path to […]